SCHEMBL30516358

SCHEMBL30516358

COc1cccc(Cn2c(C(F)(F)F)cc3c(N4CCN(C)CC4)cccc32)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.45
USP2 O75604 6/20 0.45
CYP3A4 P08684 5/20 0.45
KMT2A Q03164 4/20 0.45
MEN1 O00255 3/20 0.45
CYP1A2 P05177 3/20 0.45
CYP2D6 P10635 2/20 0.45
CYP2C9 P11712 2/20 0.45
HSD17B10 Q99714 1/20 0.45
CLK4 Q9HAZ1 1/20 0.45
HTR1A P08908 1/20 0.43
CYP2C19 P33261 2/20 0.43
POLB P06746 1/20 0.43
DRD2 P14416 1/20 0.42
DRD4 P21917 1/20 0.42
DRD3 P35462 1/20 0.42
SIGMAR1 Q99720 1/20 0.41
CASP1 P29466 3/20 0.41
CASP7 P55210 3/20 0.41
KDM4E B2RXH2 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21291613 1.00 ALDH1A1 (0.45) ALDH1A1USP2CYP3A4KMT2AMEN1
SCHEMBL30516349 0.89 HTR6 (0.49) ALDH1A1USP2CYP3A4KMT2AMEN1
SCHEMBL21291622 0.89 HTR6 (0.49) ALDH1A1USP2CYP3A4KMT2AMEN1
SCHEMBL21291614 0.87 DRD3 (0.44) ALDH1A1CYP2C9HTR1ADRD2DRD4
SCHEMBL30516359 0.87 DRD3 (0.44) ALDH1A1CYP2C9HTR1ADRD2DRD4
SCHEMBL21291605 0.86 HTR6 (0.48) ALDH1A1KMT2AMEN1HSD17B10POLB
SCHEMBL30516356 0.86 HTR6 (0.48) ALDH1A1KMT2AMEN1HSD17B10POLB
SCHEMBL21291591 0.85 HTR6 (0.48) ALDH1A1CYP3A4CYP1A2CYP2D6CYP2C9
SCHEMBL30516335 0.85 HTR6 (0.48) ALDH1A1CYP3A4CYP1A2CYP2D6CYP2C9
SCHEMBL21301982 0.85 KDM4E (0.45) ALDH1A1KMT2AMEN1POLBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112041300-B Indole and benzimidazole derivatives as dual 5-HT2A and 5-HT6 receptor antagonists 阿达梅德制药公司 2023-07-28 CN claimed
US-12319682-B2 Indole and benzimidazole derivatives as dual 5-HT2A and 5-HT6 receptor antagonists ADAMED PHARMA S.A. (PL) 2025-06-03 US disclosed
US-20240287056-A1 INDOLE AND BENZIMIDAZOLE DERIVATIVES AS DUAL 5-HT 2A AND 5-HT6 RECEPTOR ANTAGONISTS Adamed Pharma S.A (PL) 2024-08-29 US disclosed
US-11981668-B2 Indole and benzimidazole derivatives as dual 5-HT2A and 5-HT6 receptor antagonists ADAMED PHARMA S.A. (PL) 2024-05-14 US disclosed
CN-112041300-B Indole and benzimidazole derivatives as dual 5-HT2A and 5-HT6 receptor antagonists 阿达梅德制药公司 2023-07-28 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12319682-B2 Indole and benzimidazole derivatives as dual 5-HT2A and 5-HT6 receptor antagonists HTR2A, HTR6, HTR2C ALDH1A1 505/4885USP2 3013/4885CYP3A4 493/4885
US-11981668-B2 Indole and benzimidazole derivatives as dual 5-HT2A and 5-HT6 receptor antagonists HTR2A, HTR2C, HTR6 ALDH1A1 488/4885USP2 2067/4885CYP3A4 382/4885
US-20240287056-A1 INDOLE AND BENZIMIDAZOLE DERIVATIVES AS DUAL 5-HT 2A AND 5-HT6 RECEPTOR ANTAGONISTS HTR2A, HTR6, HTR2C ALDH1A1 533/4885USP2 2939/4885CYP3A4 410/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.